ACHE and Alzheimer disease: AChE is a catabolic enzyme that contributes to the breakdown of ACh in the brain, and is considered a disease-modifying therapeutic strategy in AD as well.7,8 Several drugs were developed and approved for treating AD symptoms, including tacrine, donepezil, rivastigmine, and galantamine.